Ancient Viral DNA Guards Against Infections In Human Genome
According to new research, ancient infections that left viral DNA in human genomes act as antivirals to shield human cells from some modern viruses.
A...
EMA Wants To Limit Immune-Regulating Medications Like FDA
On October 28th, an advisory board to the European Medicines Agency advised restricting the use of a class of medications for inflammatory diseases due...
China Brings To The Table First COVID Inhaler Vaccination
A new type of COVID-19 vaccination that is provided via inhalation rather than injection was this week introduced in Shanghai, the commercial city of...
Omicron Subvariants Withstand Essential Antibody Treatments
The White House issued a warning this week that HIV patients, kidney transplant recipients, and other immunocompromised people are particularly susceptible to COVID this...
Research And Development In UK Falls Behind Other Nations
According to a new report by IPPR, the UK's percentage of worldwide research and development (R&D) spending has decreased by 5% since 2014. Even...
FDA Under Strain To Amend The Accelerated Approval Program
The necessity to update and alter the FDA's now-contentious rapid approval strategy is highlighted by the protracted, complicated FDA process to discontinue commercialization of...
Prostate Cancer Screening Rates Lower With Advanced Cancers
According to data from the U.S. Department of Veterans Affairs (VA), a reduction in prostate cancer screening has been associated with a subsequent rise...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...